Full metadata record
DC FieldValueLanguage
dc.contributorFaculty of Health and Social Sciencesen_US
dc.contributor.advisorLeung, Hang Mei Polly (HTI)-
dc.creatorYau, Chong Yee Miranda-
dc.identifier.urihttps://theses.lib.polyu.edu.hk/handle/200/9398-
dc.languageEnglishen_US
dc.publisherHong Kong Polytechnic University-
dc.rightsAll rights reserveden_US
dc.titleNew strategies for culture recovery, identification, and susceptibility testing of bacteroides fragilis group organismsen_US
dcterms.abstractThe Bacteroides fragilis group (BFG) includes the most frequently isolated anaerobic bacteria. Routine culture plates are usually used for anaerobic culture investigation. The treatment for infection by anaerobes is mainly empirical, and routine antimicrobial susceptibility testing is not conducted except in the case of a serious or life-threatening infection. In recent years, the increasing resistance of these bacteria to several antibiotics has been reported, and this resistance has shown great variation in different geographic areas and at various institutions. This bacterial resistance may lead to treatment failure and adverse clinical outcomes. Aims: The aims of this study are to initiate a new strategy for culture recovery, identification, and susceptibility testing of B. fragilis group organisms to tackle the afore-mentioned drawbacks of existing practice. First, a novel B. fragilis selective (BFS) medium that can improve the sensitivity of recovery of B. fragilis from clinical samples is validated. Using a combination of matrix-assisted laser desorption ionization time-of-flight mass spectrometry and CarbaNP test, the insertion sequence, (IS) element-activated cfiA gene in B. fragilis can be detected within several hours and can then guide therapy for a B. fragilis infection more rapidly. Finally, by adopting the tentative European Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion method, the antimicrobial susceptibility pattern of B. fragilis group organisms in Hong Kong can be studied.en_US
dcterms.abstractMethods: First, validation of a novel BFS medium was performed by prospective comparison with a routinely used medium (neomycin blood agar) on 1209 clinical specimens. Second, we used the matrix-assisted laser desorption ionization Biotyper system and ClinProTools software to generate support vector machine models that were then used to differentiate cfiA-positive (division II) and cfiA-negative B. fragilis (division I). The cfiA-positive B. fragilis were then tested by CarbaNP assay. The performance parameters of these tests were assessed by genotypic analysis as reference methods. Finally, a recently developed EUCAST disk diffusion method was used to measure the susceptibility of the 741 B. fragilis group and Parabacteroides species to six antibiotics. Results: Sixty B. fragilis isolates were detected on BFS agar, and 46 were detected on neomycin blood agar (McNemar's test, p = 0.008). The sensitivities of routine and BFS plates were 70.8% (46 of 65) and 92.3% (60 of 65), respectively. In this study, the CarbaNP test for detection of an IS element in the cfiA upstream region demonstrated 100% sensitivity, 80.4% specificity, a 75.0% positive predictive value, and a 100% negative predictive value. In our B. fragilis group collection, more than 90% of isolates were susceptible to metronidazole followed by imipenem and amoxicillin-clavulanate using the tentative disk breakpoints. The E-test confirmed that 8.2% (61 of 741) and 1.6% (12 of 741) of the isolates were not susceptible to imipenem and metronidazole, respectively. Significance: In conclusion, this novel BFS medium can support the growth of B. fragilis and facilitate its differential identification in clinical specimens especially in a mixed culture. This study reveals a newly developed strategy for rapid (within 3 hours) detection of B. fragilis with the IS element-activated cfiA gene using a combination of matrix-assisted laser desorption ionization time-of-flight mass spectrometry and the CarbaNP test in a clinical laboratory. This study provides a pattern of antimicrobial susceptibility of the clinical isolates of B. fragilis and Parabacteroides species in Hong Kong and demonstrates the usefulness of the recently developed tentative EUCAST disk diffusion method for testing of resistance to imipenem, metronidazole, clindamycin, and moxifloxacin.en_US
dcterms.extent174 pages : color illustrationsen_US
dcterms.isPartOfPolyU Electronic Thesesen_US
dcterms.issued2018en_US
dcterms.educationalLevelDHScen_US
dcterms.educationalLevelAll Doctorateen_US
dcterms.LCSHHong Kong Polytechnic University -- Dissertationsen_US
dcterms.LCSHBacteroidesen_US
dcterms.accessRightsrestricted accessen_US

Files in This Item:
File Description SizeFormat 
991022109837803411.pdfFor All Users (off-campus access for PolyU Staff & Students only)2.23 MBAdobe PDFView/Open


Copyright Undertaking

As a bona fide Library user, I declare that:

  1. I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
  2. I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
  3. I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.

By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.

Show simple item record

Please use this identifier to cite or link to this item: https://theses.lib.polyu.edu.hk/handle/200/9398